Literature DB >> 5008054

Drug interaction: inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in man.

L F Gram, K F Overo.   

Abstract

Total urinary excretion of radioactivity after oral or intravenous administration of a test dose of (14)C-imipramine was measured in eight patients. They were tested before, during, and after treatment with neuroleptics. Excretion diminished while the patients were being treated with perphenazine, haloperidol, or chlorpromazine, though not during flupenthixol treatment.Total urinary excretion of radioactivity and plasma levels of metabolites and unchanged drug were measured in five patients after a test dose of (14)C-nortriptyline. Each patient was tested before and again during perphenazine treatment. In all patients perphenazine treatment caused: (1) decrease of total urinary excretion, (2) decreased plasma level of metabolites, and (3) increased plasma level of unchanged nortriptyline.These results indicate that neuroleptics inhibit the metabolism of tricyclic antidepressants in man.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5008054      PMCID: PMC1787494          DOI: 10.1136/bmj.1.5798.463

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  Induction of increased meprobamate metabolism in rats pretreated with some neurotropic drugs.

Authors:  R KATO; P VASSANELLI
Journal:  Biochem Pharmacol       Date:  1962-08       Impact factor: 5.858

2.  Application of isotope derivative technique to assay of secondary amines: estimation of desipramine by acetylation with H3-acetic anhydride.

Authors:  W M Hammer; B B Brodiet
Journal:  J Pharmacol Exp Ther       Date:  1967-09       Impact factor: 4.030

3.  Modification of chlorpromazine metabolism by some other drugs frequently administered to psychiatric patients.

Authors:  F M Forrest; I S Forrest; M T Serra
Journal:  Biol Psychiatry       Date:  1970-01       Impact factor: 13.382

4.  Pharmacology-toxicology.

Authors:  G J Cosmides
Journal:  Science       Date:  1970-05-22       Impact factor: 47.728

5.  Imipramine metabolism: pH-dependent distribution and urinary excretion.

Authors:  L F Gram; B Kofod; J Christiansen; O J Rafaelsen
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

6.  Impairment of drug metabolism in man by allopurinol and nortriptyline.

Authors:  E S Vesell; G T Passananti; F E Greene
Journal:  N Engl J Med       Date:  1970-12-31       Impact factor: 91.245

Review 7.  Enhancement and inhibition of drug metabolism.

Authors:  M W Anders
Journal:  Annu Rev Pharmacol       Date:  1971       Impact factor: 13.820

8.  Plasma levels of imipramine and desmethylimipramine during therapy.

Authors:  J P Moody; A C Tait; A Todrick
Journal:  Br J Psychiatry       Date:  1967-02       Impact factor: 9.319

9.  Relationship between plasma level and therapeutic effect of nortriptyline.

Authors:  M Asberg; B Crönholm; F Sjöqvist; D Tuck
Journal:  Br Med J       Date:  1971-08-07

10.  Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy.

Authors:  B Alexanderson; D A Evans; F Sjöqvist
Journal:  Br Med J       Date:  1969-12-27
View more
  38 in total

1.  The relationship between nortriptyline plasms levels and clinical effects.

Authors:  P Kragh-Sorensen
Journal:  Proc R Soc Med       Date:  1975-02

Review 2.  Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs.

Authors:  Candace S Brown; Richard G Farmer; Judith E Soberman; Samantha F Eichner
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

3.  The radioimmunoassay of tricyclic antidepressants.

Authors:  G W Aherne; E M Piall; V Marks
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

4.  The effect of fluphenazine on steady state plasma levels of nortriptyline.

Authors:  I H Stevenson; A A Schiff
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

Review 5.  Polymorphic cytochromes P450 and drugs used in psychiatry.

Authors:  R T Coutts; L J Urichuk
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

6.  Effect of long-term phenothiazine treatment on drug metabolism.

Authors:  T Kolakowska; M Franklin; B Alapin
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

7.  Population pharmacokinetics and pharmacodynamics: potential use for gathering dose-concentration-response.

Authors:  M Jerling
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

8.  The significance of drug interactions in the evaluation of psychotropic drugs.

Authors:  R A Braithwaite
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

Review 9.  Plasma level monitoring of antipsychotic drugs.

Authors:  T B Cooper
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

10.  Effect of simultaneous treatment with low doses of perphenazine on plasma and urine concentrations of nortriptyline and 10-hydroxynortriptyline.

Authors:  P Kragh-Sorensen; O Borgå; M Garle; L Bolvig Hansen; C E Hansen; E F Hvidberg; N E Larsen; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1977-07-19       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.